Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 9.02
-0.43 (-4.55%)
At close: Aug 21, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 20.14 billion as of August 21, 2026. Its market cap has decreased by -27.54% in one year.
Market Cap
20.14B
Enterprise Value
20.71B
Revenue
4.41B
Ranking
n/a
PE Ratio
34.48
Stock Price
9.02
ChartMarket Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 20.14B, a decrease of -9.87%. That is a compound annual growth rate of -2.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 20.14B | -10.96% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chongqing Zhifei Biological Products | 28.89B |
| Xiamen Amoytop Biotech | 26.53B |
| Beijing Tiantan Biological Products | 25.11B |
| Hualan Biological Engineering | 24.72B |
| Hebei Changshan Biochemical Pharmaceutical | 23.48B |
| Sinocelltech Group | 19.26B |
| Anhui Anke Biotechnology (Group) | 16.92B |
| BrightGene Bio-Medical Technology | 16.91B |